CEO Roundtable on Cancer, Inc.

In 2001, former President George H.W. Bush asked Robert A. Ingram, then the CEO of GlaxoWellcome, to form an organization comprising action-oriented chief executives and challenged them to “do something bold and venturesome about cancer within your own corporate families.

President Bush also requested that Dr. Martin J. Murphy take the role as Founding CEO of the Roundtable on Cancer, a position that he held until January 2020.

Today, the CEO Roundtable on Cancer, Inc., chartered as a 501(c)(3) nonprofit organization, works to develop and implement initiatives that reduce the risk of cancer, enable early diagnosis, facilitate access to the best available treatments, and hasten the discovery of novel and more effective anti-cancer therapies to help eliminate cancer as a personal disease and public health problem.

Two ways the CEO Roundtable on Cancer is advancing this vision is with the CEO Cancer Gold Standard™, an employer-led, wellness accreditation program addressing prevention, diagnosis and quality treatment of cancer, and with the CEO Roundtable on Cancer-China, a non-governmental organization (NGO), bringing this employer-led health and wellness model to China.

Each November, the CEO Roundtable on Cancer convenes its annual meeting at SAS headquarters in Cary, NC. In 2018, at CEO Roundtable VXII, Project Data Sphere held a first-ever breakout session as part of the meeting, giving attendees the option of learning more about PDS' myriad collaborations, research programs, and platform enhancements.

CEO Roundtable on Cancer Board of Directors
Robert Bradway
Robert Bradway
Immediate Past Chairman
Chairman and Chief Executive Officer, Amgen
Ken Lee
Kenneth B. Lee, Jr.
Board Chairman
Chief Executive Officer, CEO Roundtable on Cancer and Project Data Sphere®
Scott White
Scott White
Board Member
Company Group Chairman, North America Pharmaceuticals, Johnson & Johnson
Belen Garijo
Belen Garijo, MD
Board Member
Vice Chair, Executive Board, and Deputy CEO, Merck KGaA, Darmstad, Germany
Robert Ingram
Robert Ingram
Founding Chairman
General Partner, Hatteras Venture Partners
Peter Pisters
Peter Pisters, MD
Board Member
President, University of Texas MD Anderson Cancer Center
Christopher Viehbacher
Christopher Viehbacher
Past Chairman
Managing Partner, Gurnet Point Capital
CEO Roundtable on Cancer Emeritus Directors
Martin J. Murphy
Director Emeritis
CEO Roundtable on Cancer
William C. Weldon
Director Emeritus
CEO Roundtable on Cancer

Life Sciences Consortium

The Life Sciences Consortium (LSC) was formed in 2005 to bring together representatives of oncology pharmaceutical / biotechnology companies to advise the CEO Roundtable on Cancer about ways to enable research and development to deliver more effective oncology therapies to patients faster.

That advice led the CEO Roundtable on Cancer to create the independent, non-profit Project Data Sphere (PDS) in 2014 to provide a digital library-laboratory to share, integrate and analyze clinical trial data.  

The LSC continues to advise the Roundtable and Project Data Sphere on  issues common to companies engaged in cancer drug discovery and development that cannot be solved by any company alone.

Those issues include how to:

  • Improve clinical trial delivery
  • Help streamline the regulatory process
  • Create a pre-competitive pool of intellectual property that all may use for discovery and development
Life Sciences Consortium Task Force
David Reese
David Reese
Co-Chair Life Sciences Consortium Task Force
Executive Vice President of Research and Development, Amgen
Mace Rothenberg
Mace Rothenberg
Co-Chair Life Sciences Consortium Task Force
Special Advisor, Pfizer
Sean Khozin, MD, MPH
Life Sciences Consortium Task Force Member
Chief Executive Officer, CancerLinQ
Maria Rivas, MD
Life Sciences Consortium Task Force Member
Chief Medical Officer, Merck KGaA, Darmstadt, Germany
Roy D. Baynes, MD, PhD
Life Sciences Consortium Task Force Member
Senior Vice President, Global Clinical Development, and Chief Medical Officer, Merck Research Laboratories
Craig L. Tendler
Life Sciences Consortium Task Force Member
Vice President, Clinical Development and Global Medical Affairs, Oncology, Janssen Research & Development, LLC